Release Notes; Version 20180813

DateAugust 13 2018
AccessTerminology Gateway
Release TypeMaintenance Release

About this maintenance release 

This release includes the Canadian Clinical Drug Data Set files (version 20180813).  

The Editorial Guidelines and the Technical Specification have not been revised with this release. 

The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.  Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page where all the standards are provided.  

General Notes

The following files will be available as full release files within this version:

  • Manufactured Product,
  • Non-proprietary Therapeutic Product,
  • Therapeutic Moiety,
  • Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
  • Special Groupings, 
  • Coded Attribute, and
  • Device Non-proprietary Therapeutic Product.

The 'Full" release contains one entry for every concept that has ever been released and new content added for that release.   New content added for a specific release may at times include “Inactive” content.

The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be provided in a future release.  

This release continues to add additional content from the DPD and includes most of the top 250 moieties and approximately 71% of the DPD content.  

The table below provides the number of concepts within each CCDD file for this release.

August 2018 CCDD Files
Number of Concepts
Types of Changes in this release
Therapeutic Moiety Full Release720

96 additions

1 status change from active to inactive

1 status date change (no change in status)

Non-proprietary Therapeutic Product Full Release2420

209 additions (206 for new TMs and 3 for existing TMs)

3 Formal Name changes (see details below)

12 status changes (Active to Inactive)

2 status date changes (with no change of status)

9 existing deprecated concepts changed status date

Manufactured Product Full Release8170

366 additions

  • 63 MPs for existing TMs
  • 303 for new TMs

Formal name changes made:

  • 6 DPD company change
  • 12 DPD product name changes
  • 1 Formal Name change due to a new NTP
  • 37 Formal Name changes (see details below)
  • 7 DPD company and product name changes

98 status changes (Active to Inactive)

8 status changes (Inactive to Active)

4 status date changes (no change of status)

Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Moiety Relationship

8169

Includes concept additions and changes as above

Deprecated concepts have been excluded.

Device Non-proprietary Therapeutic Product3no change
Special Groupings1500

3 additions

1 updated entry due to an updated MP Formal Name

Coded Attributes7

no change

NTP Specific Comments

The following table provides the concepts with the change in Formal Name from the previous release.  Please note some changes include the removal of a space in the Formal Name.

August Release July Release
NTP codeNTP Formal Name NTP codeNTP Formal Name
9012633hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vialCorrected formal name9012633hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial
9012634hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vialCorrected formal name9012634hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial
9009401ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tabletCorrected formal name9009401ethinyl estradiol 35 mcg and norgestimate 250 mcg with lactose oral tablet


MP Specific Comments

The following table provides the concepts with the change in Formal Name from the previous release due to a change in the CCDD name generation process to bring these in line with the Editorial Guidelines.  Changes to MP Formal Name due to product or company name changes in the DPD are not detailed in the table below..  Please note some changes include the removal of a space in the Formal Name.

August Release July Release
MP codeMP Formal Name MP codeMP Formal Name
02247021RATIO-ACLAVULANATE (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) TEVA CANADA LIMITEDMP formal name change02247021RATIO-ACLAVULANATE (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (clavulanate potassium) 125 mg oral tablet) TEVA CANADA LIMITED
02311321PRO-ISMN - 60 (isosorbide mononitrate 60 mg prolonged-release oral tablet) PRO DOC LIMITEEMP formal name change02311321PRO-ISMN - 60 (isosorbide-5-mononitrate 60 mg prolonged-release oral tablet) PRO DOC LIMITEE
00030635SOLU-CORTEF 1 GM ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA INCMP formal name change00030635SOLU-CORTEF 1 GM ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA INC
01916882CLAVULIN 125 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension) GLAXOSMITHKLINE INCMP formal name change01916882CLAVULIN 125 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (clavulanate potassium) 31.25 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC
00821772D-TABS 10000UNIT (vitamin D3 (cholecalciferol) 10000 unit oral tablet) LABORATOIRE RIVA INCMP formal name change00821772D-TABS 10000UNIT (vitamin D3 10000 unit oral tablet) LABORATOIRE RIVA INC
02442272VITAMIN D3-SOFTGEL CAPSULES 10000 IU (vitamin D3 (cholecalciferol) 10000 unit oral capsule) ORIMED PHARMA INCMP formal name change02442272VITAMIN D3-SOFTGEL CAPSULES 10000 IU (vitamin D3 10000 unit oral capsule) ORIMED PHARMA INC
02272830APO-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) APOTEX INCMP formal name change02272830APO-ISMN (isosorbide-5-mononitrate 60 mg prolonged-release oral tablet) APOTEX INC
02288559APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) APOTEX INCMP formal name change02288559APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (clavulanate potassium) 57 mg per 5 mL oral suspension) APOTEX INC
02243240DIAZEPAM AUTOINJECTOR (diazepam 10 mg per 2 mL solution for injection syringe) MERIDIAN MEDICAL TECHNOLOGIES INC.MP formal name change02243240DIAZEPAM AUTOINJECTOR (diazepam 10 mg per 2 mL solution for injection ampoule) MERIDIAN MEDICAL TECHNOLOGIES INC.
01959239HUMULIN N (CARTRIDGE) (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INCMP formal name change01959239HUMULIN N (CARTRIDGE) (insulin isophane human biosynthetic 100 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC
02024225NOVOLIN GE NPH (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INCMP formal name change02024225NOVOLIN GE NPH (insulin isophane human biosynthetic 100 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INC
02024268NOVOLIN GE NPH PENFILL (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INCMP formal name change02024268NOVOLIN GE NPH PENFILL (insulin isophane human biosynthetic 100 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC
02403447HUMULIN N (KWIKPEN) (insulin isophane human 100 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INCMP formal name change02403447HUMULIN N (KWIKPEN) (insulin isophane human biosynthetic 100 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC
00587737HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INCMP formal name change00587737HUMULIN N (insulin nph human dna origin 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC
02238829CLAVULIN 875 (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) GLAXOSMITHKLINE INCMP formal name change02238829CLAVULIN 875 (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (clavulanate potassium) 125 mg oral tablet) GLAXOSMITHKLINE INC
02379007JAMP-VITAMIN D (vitamin D3 (cholecalciferol) 10000 unit oral tablet) JAMP PHARMA CORPORATIONMP formal name change02379007JAMP-VITAMIN D (vitamin D3 10000 unit oral tablet) JAMP PHARMA CORPORATION
02449099JAMP-VITAMIN D (vitamin D3 (cholecalciferol) 10000 unit oral capsule) JAMP PHARMA CORPORATIONMP formal name change02449099JAMP-VITAMIN D (vitamin D3 10000 unit oral capsule) JAMP PHARMA CORPORATION
02126559IMDUR (isosorbide mononitrate 60 mg prolonged-release oral tablet) ASTRAZENECA CANADA INCMP formal name change02126559IMDUR - EXTENDED RELEASE TABLETS 60 MG (isosorbide-5-mononitrate 60 mg prolonged-release oral tablet) ASTRAZENECA CANADA INC
02417995VITAMINE D 10 000 (vitamin D3 (cholecalciferol) 10000 unit oral tablet) PRO DOC LIMITEEMP formal name change02417995VITAMINE D 10 000 (vitamin D3 10000 unit oral tablet) PRO DOC LIMITEE
02449110JAMP-VITAMIN D (vitamin D3 (cholecalciferol) 50000 unit oral capsule) JAMP PHARMA CORPORATIONMP formal name change02449110JAMP-VITAMIN D (vitamin D3 50000 unit oral capsule) JAMP PHARMA CORPORATION
02301288PMS-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) PHARMASCIENCE INCMP formal name change02301288PMS-ISMN (isosorbide-5-mononitrate 60 mg prolonged-release oral tablet) PHARMASCIENCE INC
00602965ORTHO 7/7/7 TABLETS (28 DAY) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.75 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) JANSSEN INCMP formal name change00602965ORTHO 7/7/7 TABLETS (28 DAY) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.75 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) JANSSEN INC
02238831CLAVULIN 200 (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INCMP formal name change02238831CLAVULIN 200 (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (clavulanate potassium) 28.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC
02237835BETAJECT (betamethasone acetate 3 mg per mL and betamethasone (betamethasone sodium phosphate) 3 mg per mL suspension for injection) SANDOZ CANADA INCORPORATEDMP formal name change02237835BETAJECT (betamethasone acetate 3 mg per mL and betamethasone (betamethasone 21-disodium phosphate) 3 mg per mL suspension for injection) SANDOZ CANADA INCORPORATED
02442256LUXA-D (vitamin D3 (cholecalciferol) 2000 unit oral capsule) ORIMED PHARMA INCMP formal name change02442256LUXA-D (vitamin D3 2000 unit oral capsule) ORIMED PHARMA INC
02238830CLAVULIN 400 (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) GLAXOSMITHKLINE INCMP formal name change02238830CLAVULIN 400 (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (clavulanate potassium) 57 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC
02371499EURO-D 10000 IU (vitamin D3 (cholecalciferol) 10000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INCMP formal name change02371499EURO-D 10000 IU (vitamin D3 10000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC
02446073ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULCMP formal name change02446073ISMN (isosorbide-5-mononitrate 60 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC
01916874CLAVULIN 250 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INCMP formal name change01916874CLAVULIN 250 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (clavulanate potassium) 62.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC
02442280LUXA-D (vitamin D3 (cholecalciferol) 25000 unit oral capsule) ORIMED PHARMA INCMP formal name change02442280LUXA-D (vitamin D3 25000 unit oral capsule) ORIMED PHARMA INC
02442299LUXA-D (vitamin D3 (cholecalciferol) 50000 unit oral capsule) ORIMED PHARMA INCMP formal name change02442299LUXA-D (vitamin D3 50000 unit oral capsule) ORIMED PHARMA INC
02442264LUXA-D (vitamin D3 (cholecalciferol) 5000 unit oral capsule) ORIMED PHARMA INCMP formal name change02442264LUXA-D (vitamin D3 5000 unit oral capsule) ORIMED PHARMA INC
00602957ORTHO 7/7/7 TABLETS (21 DAY) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.75 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) JANSSEN INCMP formal name change00602957ORTHO 7/7/7 TABLETS (21 DAY) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.75 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablett) JANSSEN INC
02417685VIDEXTRA (vitamin D3 (cholecalciferol) 10000 unit oral tablet) ORIMED PHARMA INCMP formal name change02417685VIDEXTRA (vitamin D3 10000 unit oral tablet) ORIMED PHARMA INC
02244646RATIO-ACLAVULANATE 125 F (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension) TEVA CANADA LIMITEDMP formal name change02244646RATIO-ACLAVULANATE 125 F (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (clavulanate potassium) 31.25 mg per 5 mL oral suspension) TEVA CANADA LIMITED
01916858CLAVULIN 500 F TAB (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) GLAXOSMITHKLINE INCMP formal name change01916858CLAVULIN 500 F TAB (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (clavulanate potassium) 125 mg oral tablet) GLAXOSMITHKLINE INC
02371502EURO-D 50000 IU (vitamin D3 (cholecalciferol) 50000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INCMP formal name change02371502EURO-D 50000 IU (vitamin D3 50000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC


It is the intent of the CCDD formal names to always be unique.  However, in this release there remains a few Manufactured Product concept formal names that did not generate uniquely following the CCDD Manufactured Product naming pattern as documented in the MP Formal Name Pattern section of the Editorial Guidelines. See below for an example:

02028174

ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC

02025337

ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC

This lack of unique formal names for the Manufactured Product is on the road map to be addressed in the future.

Terminology Gateway Specific Comments

A link to the Release notes on this page has been added to the Gateway CCDD files.  Users may use the  "Change Logs"  available when viewing each individual file on the Gateway.  The change logs identify the additions and changes to a code or formal name only. If there has been a change to a status or status date, it will not appear in the change log at this time.

Questions, Concerns, Changes

Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]

Please note that to access InfoCentral, you must have an Infoway login.  If you have any questions about any of our standards or products, please contact the Infodesk Desk at: 

Toll Free #: 1-877-595-3417 or 416-595-3417 

E-mail: [email protected] 

  • No labels